visual-image

Epilepsy is a truly interdisciplinary specialty. The Columbia Comprehensive Epilepsy Center (CCEC) is a global leader in epilepsy diagnosis and treatment, made up of dedicated specialists in epilepsy neurology, neurophysiology, neuroradiology, neuropsychology, and neurosurgery.

Epilepsy is a truly interdisciplinary specialty. The Columbia Comprehensive Epilepsy Center(CCEC) is a global leader in epilepsy diagnosis and treatment, made up of dedicated specialists in epilepsy neurology, neurophysiology, neuroradiology, neuropsychology, and neurosurgery. The CCEC is equipped with state-of-the-art adult and pediatric epilepsy monitoring units at Columbia University Medical Center and the Morgan Stanley Children’s Hospital.

For forms of epilepsy that cannot be adequately controlled with antiseizure medications, epilepsy surgery is the best and often the only chance of seizure control or cure. A variety of highly specialized techniques are applied to maximize the efficacy and safety of epilepsy surgical procedures.

Members of the Department of Neurosurgery, Dr. Sameer A. Sheth (Adult Epilepsy), Dr. Guy McKhann (Adult and Pediatric Epilepsy), and Dr. Neil Feldstein (Pediatric Epilepsy) comprise one of the most experienced and skilled epilepsy surgery teams in the world. Research consistently finds that experienced surgeons at neuroscience centers of excellence achieve the best possible patient outcomes.

With the CCEC, our epilepsy surgery team is continually engaged in clinical investigations of all of the major epilepsy surgical therapies currently under trial as part of multi-institutional NIH- or industry-sponsored studies, such as responsive brain stimulation (RNS), deep brain stimulation (DBS) (for various forms of focal epilepsy); gamma knife radiosurgery for the treatment of temporal lobe epilepsy, and the investigation of a multichannel microelectrode for microseizure detection.

Be Sociable, Share!
 
59

Latest News

Featured Article

McKhannTN Dr. Guy McKhann Brings Good News to Epilepsy Patients: Implantable Device to Control Seizures Now Available

The U.S. Food and Drug Administration (FDA) has just approved the Neuropace RNS Stimulator, an implantable device shown to reduce the frequency of seizures in epilepsy patients. The device is comprised of a small neurostimulator that is implanted in the skull under the skin and two electrodes placed on or near the part of the brain where the patient's seizures arise...